Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Total 13F shares
-
6,986,676
-
Share change
-
+2,485,731
-
Total reported value
-
$4,403,981
-
Price per share
-
$0.63
-
Number of holders
-
28
-
Value change
-
+$1,247,989
-
Number of buys
-
9
-
Number of sells
-
27
Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q3 2019
As of 30 Sep 2019,
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,986,676 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, SIGNATUREFD, LLC, FIRST MANHATTAN CO, Tekla Capital Management LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.